Veterinary Medicines

Fatroximin, soluzione spray per uso topico Per bovini, ovi-caprini, suini, equini, conigli, cani e gatti

Authorised
  • Rifaximin
Download as PDF

Product identification

Medicine name:
Fatroximin, soluzione spray per uso topico Per bovini, ovi-caprini, suini, equini, conigli, cani e gatti
Active substance:
  • Rifaximin
Target species:
  • Dog
  • Cat
  • Cattle
  • Sheep
  • Goat
  • Pig
  • Rabbit
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Rifaximin
    0.50
    gram(s)
    /
    1.00
    Cylinder
Pharmaceutical form:
  • Cutaneous spray, solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
    • Cat
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Sheep
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Goat
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Pig
      • Meat and offal
        0
        day
    • Rabbit
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QG51AA06
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Fatro S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Fatro S.p.A.
Responsible authority:
  • Ministry Of Health
Authorisation number:
  • 100077
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 12/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."